ALPMY
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)
$29
About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$17.35
52 Week Low
$10.03
Market cap
25.3B
Dividend yield
3.51%
Volume
--
Avg. volume
191,746
P/E ratio
13.04
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$17.35
52 Week Low
$10.03
Market cap
25.3B
Dividend yield
3.51%
Volume
--
Avg. volume
191,746
P/E ratio
13.04